John Couling Sells 4,688 Shares of Dolby Laboratories (NYSE:DLB) Stock

May 7, 2026 by InsiderTrades.com

Key Points

SVP John Couling sold 4,688 shares on May 4 at an average price of $58.47 (≈$274,107), reducing his stake by 3.81% to 118,353 shares valued at about $6.92M.
Dolby beat expectations in its most recent quarter with EPS of $1.37 vs. $1.31 expected and revenue of $395.6M vs. $385.8M, and it set FY2026 guidance at $4.30–$4.45 EPS (Q3 2026 guidance $0.56–$0.71).
Dividend announced: a quarterly payout of $0.36 ($1.44 annual, ~2.5% yield) with an ex-dividend date of May 12 and payment on May 20.

Dolby Laboratories (NYSE:DLB - Get Free Report) SVP John Couling sold 4,688 shares of the stock in a transaction dated Monday, May 4th. The stock was sold at an average price of $58.47, for a total value of $274,107.36. Following the sale, the senior vice president directly owned 118,353 shares in the company, valued at $6,920,099.91. This trade represents a 3.81% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Dolby Laboratories Stock Performance

Big Screen Stock Soars on Blockbuster Q2 Earnings

Shares of DLB opened at $58.11 on Thursday. The stock's 50-day simple moving average is $62.37 and its 200 day simple moving average is $64.35. The stock has a market capitalization of $5.55 billion, a price-to-earnings ratio of 22.97 and a beta of 0.86. Dolby Laboratories has a 52-week low of $55.73 and a 52-week high of $78.28.

Dolby Laboratories (NYSE:DLB - Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.31 by $0.06. The business had revenue of $395.63 million for the quarter, compared to analysts' expectations of $385.80 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The firm's quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.34 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, research analysts forecast that Dolby Laboratories will post 3.25 earnings per share for the current fiscal year.

Dolby Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th will be paid a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date is Tuesday, May 12th. Dolby Laboratories's dividend payout ratio is currently 56.92%.

Hedge Funds Weigh In On Dolby Laboratories

Several institutional investors have recently modified their holdings of DLB. Norges Bank bought a new position in shares of Dolby Laboratories during the 4th quarter valued at about $54,966,000. AQR Capital Management LLC increased its position in shares of Dolby Laboratories by 51.8% during the 2nd quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker's stock valued at $128,935,000 after purchasing an additional 592,282 shares during the last quarter. Alyeska Investment Group L.P. bought a new position in shares of Dolby Laboratories during the 4th quarter valued at about $23,477,000. First Trust Advisors LP grew its position in Dolby Laboratories by 23.8% during the 4th quarter. First Trust Advisors LP now owns 1,880,528 shares of the electronics maker's stock worth $120,768,000 after acquiring an additional 361,871 shares during the last quarter. Finally, Voloridge Investment Management LLC grew its position in Dolby Laboratories by 2,017.9% during the 4th quarter. Voloridge Investment Management LLC now owns 325,499 shares of the electronics maker's stock worth $20,904,000 after acquiring an additional 310,130 shares during the last quarter. 58.56% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Weiss Ratings restated a "hold (c-)" rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Barrington Research restated an "outperform" rating and issued a $90.00 target price on shares of Dolby Laboratories in a research note on Monday, April 27th. Wall Street Zen lowered Dolby Laboratories from a "buy" rating to a "hold" rating in a research note on Saturday, January 31st. Finally, Rosenblatt Securities restated a "buy" rating and issued a $85.00 target price on shares of Dolby Laboratories in a research note on Friday, January 30th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $90.75.

Check Out Our Latest Stock Report on DLB

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company's core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby's licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.